Company intelligence / Profile preview

Hecosol

Ownership: Private
Development stage: Commercial

Overview

Hecosol develops and commercializes advanced antimicrobial surface coatings designed to improve hygiene, reduce infection risk, protect against mold infestation in food environments, lower energy consumption for air systems, and minimize the need for chemical cleaning agents. Their products have been validated through tests and best-practice studies[2].

Therapeutic areas: Infectious Diseases
Modalities: Antimicrobial coatingSurface protection technology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Hecosol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hecosol.

Explore the full profile